Settlement Reached in Misconduct Case

A cancer researcher found guilty of misconduct has reached a settlement with the ORI that allows him to apply for federal research funding.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, GALLO & SPERO LLPThe Office of Research Integrity (ORI) has reached a settlement agreement with cancer biologist and biochemist Phillippe Bois, who was found guilty of research misconduct in 2011 and barred from applying for federal grants for 3 years. Bois filed a lawsuit to the District Court to overturn the penalty, and the subsequent settlement means he is eligible to apply for federal research funding—though he will no longer seek to appeal the ORI’s findings, according to an announcement published yesterday (April 18) in the Federal Register.

“I have been fighting to clear my name for almost 7 years, and I am glad to be able to put this matter behind and to move on with my career in science,” said Bois in a statement released by his defense attorneys. “ORI’s decision to cease seeking a debarment is a clear signal to me that its findings would not have been sustained by a judge and that its proposed punishment, a three-year debarment, was excessive and unreasonable.”

In May 2011 the ORI found that Bois had committed two counts of research misconduct while working at St. Jude Children’s Research Hospital in Memphis, Tennessee: he had falsified an image to conceal unwanted results for a paper in the Journal of Cell Biology, which was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Dan Cossins

    This person does not yet have a bio.
Share
A greyscale image of cells dividing.
March 2025, Issue 1

How Do Embryos Know How Fast to Develop

In mammals, intracellular clocks begin to tick within days of fertilization.

View this Issue
Discover the history, mechanics, and potential of PCR.

Become a PCR Pro

Integra Logo
Explore polypharmacology’s beneficial role in target-based drug discovery

Embracing Polypharmacology for Multipurpose Drug Targeting

Fortis Life Sciences
3D rendered cross section of influenza viruses, showing surface proteins on the outside and single stranded RNA inside the virus

Genetic Insights Break Infectious Pathogen Barriers

Thermo Fisher Logo
A photo of sample storage boxes in an ultra-low temperature freezer.

Navigating Cold Storage Solutions

PHCbi logo 

Products

Zymo Logo

Zymo Research Launches the Quick-16S™ Full-Length Library Prep Kit

BIOVECTRA

BIOVECTRA is Honored with 2025 CDMO Leadership Award for Biologics

Sino Logo

Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV

Stirling Ultracold

Meet the Upright ULT Built for Faster Recovery - Stirling VAULT100™

Stirling Ultracold logo